Crossmark

TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation

Crossref DOI link: https://doi.org/10.1007/s00262-024-03672-y

Published Online: 2024-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niu, Zihao

Sun, Peng

Zafereo, Mark E.

Liu, Hongliang

Wei, Peng

Wu, Jia

Gross, Neil D.

Shete, Sanjay

Wei, Qingyi

Zheng, Guibin

Sikora, Andy G.

Calin, George A.

Li, Guojun
License Information

Text and Data Mining valid from 2024-03-30

Version of Record valid from 2024-03-30
More Information

Article History

Received: 20 December 2023

Accepted: 8 March 2024

First Online: 30 March 2024

Declarations

:

: This study was approved by the Institutional Review Board of MD Anderson Cancer Center, USA.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below